Bevasiranib API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Bevasiranib API 959961-96-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Bevasiranib. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Bevasiranib
- Synonyms:
- Cas Number:
- 959961-96-7
- DrugBank number:
- DB06642
- Unique Ingredient Identifier:
- DGN36694W4
General Description:
Bevasiranib, identified by CAS number 959961-96-7, is a notable compound with significant therapeutic applications. Bevasiranib is a small interfering RNA (siRNA) targeting vascular endothelial growth factor A (VEGF-A).
Indications:
This drug is primarily indicated for: Investigated for use/treatment in macular degeneration and diabetic retinopathy. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Pharmacodynamics:
Bevasiranib exerts its therapeutic effects through: Bevasiranib represents the first drug in a promising new class of experimental medical treatments. It is a small interfering RNA (siRNA) drug, which silences the genes that produce Vascular Endothelial Growth Factor (VEGF), a protein that promotes blood vessel growth. The treatment slows the growth and leakage of abnormal blood vessels that are associated with the wet form of macular degeneration. The drug is injected directly into the eye. The drug's ability to modulate various physiological processes underscores its efficacy in treating specific conditions.
Categories:
Bevasiranib is categorized under the following therapeutic classes: Antisense Elements (Genetics), Compounds used in a research, industrial, or household setting, Molecular Probes, Nucleic Acid Probes, Nucleic Acids, Nucleic Acids, Nucleotides, and Nucleosides, RNA, Antisense, RNA, Small Untranslated, RNA, Untranslated. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
